A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)

Stopped Sponsor decision to terminate; sufficient sample size for statistical analysis has been achieved.

Conditions

• Hemophilia A

Interventions

• PROCEDURE: Biospecimen Collection

Sponsor

BioMarin Pharmaceutical